Search Results - "Friso, Stefano"

Malignant Bowel Obstruction in Ovarian Cancer Recurrence: The Role of Palliative Surgery in a Decision-Making Process by De Crescenzo, Eugenia, Fontana, Marianna, Dondi, Giulia, Friso, Stefano, Bovicelli, Alessandro, Di Stanislao, Marco, Tesei, Marco, De Palma, Alessandra, Chieco, Pasquale, Rottoli, Matteo, Bernante, Paolo, Ravegnini, Gloria, Perrone, Anna Myriam, De Iaco, Pierandrea

“…Background: Malignant bowel obstruction (MBO) is often the latest stage in ovarian cancer (OC). The therapy of this condition ranges from medical waiting to…”
Get full text

Increasing BMI is associated with both endometrioid and serous histotypes among endometrial rather than ovarian cancers: a case-to-case study by Grandi, Giovanni, Perrone, Anna Myriam, Chiossi, Giuseppe, Friso, Stefano, Toss, Angela, Sammarini, Margaret, Facchinetti, Fabio, Botticelli, Laura, Palma, Federica, De Iaco, Pierandrea

“…Although obesity has been associated with endometrioid (type I) and, to a lesser extent, with serous (type II) endometrial cancer (EC), the association with…”
Get full text

Prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers: what is going on in a region of northern Italy? by Grandi, Giovanni, Perrone, Anna Myriam, Perrone, Antonino, Mandato, Vincenzo Dario, Comerci, Giuseppe, Sammarini, Margaret, Merisio, Carla, Amadori, Andrea, Stefanetti, Marco, Martinello, Ruby, Facchinetti, Fabio, De Iaco, Pierandrea, Aguzzoli, Lorenzo, Arcangeli, Valentina, Berretta, Roberto, Cortesi, Laura, De Domenico, Roberta, Nuzzo, Maria De, Friso, Stefano, Greco, Pantaleo, Rosati, Federica, Scutiero, Gennaro, Toss, Angela

“…•Breast cancer survivors underwent risk-reducing salpingo-oophorectomy at a younger age.•The temporal trend for the age distribution of risk-reducing…”
Get full text

The generally low sensitivity of CA 125 for FIGO stage I ovarian cancer diagnosis increases for endometrioid histotype by Grandi, Giovanni, Perrone, Anna M, Toss, Angela, Vitagliano, Amerigo, Friso, Stefano, Facchinetti, Fabio, Cortesi, Laura, Cascinu, Stefano, De Iaco, Pierandrea

“…The serum marker CA 125 is still the most widely used biomarker for ovarian cancer (OC) diagnosis in gynecological and oncological setting, but its predictive…”
Get more information